l9n/ Mississippi

2022 Regular Session

Senate Bill 2283

Uniform Controlled Substances Act; revise schedules.

Did not become law. It stopped in the House of Representatives's Drug Policy Committee on March 1, 2022. The 2022 session has ended.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO INCLUDE 20 FENTANYL-RELATED SUBSTANCES, MT-45, NM2201, 5F-CUMYL-P7AICA AND PMMA AS SCHEDULE I CONTROLLED SUBSTANCES BECAUSE THESE DRUGS HAVE NO LEGITIMATE MEDICAL USE AND HAVE A HIGH POTENCY WITH GREAT POTENTIAL TO CAUSE HARM; TO ALPHABETIZE CERTAIN SUBSTANCES TO CONFORM THE LIST OF SCHEDULE I OPIATES TO THE CODE OF FEDERAL REGULATIONS; TO AMEND SECTION 41-29-115, MISSISSIPPI CODE OF 1972, TO INCLUDE OLICERIDINE AS A SCHEDULE II CONTROLLED SUBSTANCE BECAUSE OLICERIDINE HAS A CURRENTLY ACCEPTED MEDICAL USE BUT HAS A HIGH POTENTIAL FOR ABUSE THAT MAY LEAD TO SEVERE PSYCHOLOGICAL OR PHYSICAL DEPENDENCE; TO AMEND SECTION 41-29-119, MISSISSIPPI CODE OF 1972, TO INCLUDE LEMBOREXANT AND REMIMAZOLAM AS SCHEDULE IV CONTROLLED SUBSTANCES BECAUSE THESE DRUGS HAVE A CURRENTLY ACCEPTED MEDICAL USE AND A LOW POTENTIAL FOR ABUSE THAT MAY LEAD TO LIMITED PHYSICAL DEPENDENCE OR PSYCHOLOGICAL DEPENDENCE RELATIVE TO THE DRUGS OR OTHER SUBSTANCES IN SCHEDULE III; TO AMEND SECTION 41-29-121, MISSISSIPPI CODE OF 1972, TO INCLUDE CENOBAMATE AND LASMIDITAN AS SCHEDULE V CONTROLLED SUBSTANCES BECAUSE THESE DRUGS HAVE A CURRENTLY ACCEPTED MEDICAL USE AND A LOW POTENTIAL FOR ABUSE THAT MAY LEAD TO LIMITED PHYSICAL DEPENDENCE OR PSYCHOLOGICAL DEPENDENCE RELATIVE TO THE DRUGS OR OTHER SUBSTANCES IN SCHEDULE IV; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Robert L. Jackson

Its course

January 17 to March 1, 2022, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action7 actions on 5 days

In the SenateJan 17 to Feb 923 days

Drug PolicyJan 17 to Feb 115 days

Judiciary, Division BFeb 1 to Feb 10 days

In the House of RepresentativesFeb 9 to Mar 1 · stopped20 days

Drug PolicyFeb 10 to Mar 1 · stopped19 days

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the Senate Jan 17 – Feb 9

  1. Jan 17Referred to the Senate committees on Drug Policy and on Judiciary, Division B
  2. Feb 1Reported from DP to JB in the Senate: title sufficient, do pass
  3. Reported from committee in the Senate: title sufficient, do pass
  4. Feb 9Passed the Senate

In the House of Representatives Feb 10 – Mar 1

  1. Feb 10Sent to the House
  2. Referred to the House committee on Drug Policy
  3. Mar 1Died in committee in the House
All 7 actions, as published
  1. Jan 17Referred To Drug Policy;Judiciary, Division BSenate
  2. Feb 1DR - TSDP: DP To JBSenate
  3. Feb 1Title Suff Do PassSenate
  4. Feb 9PassedSenate
  5. Feb 10Transmitted To HouseSenate
  6. Feb 10Referred To Drug PolicyHouse of Representatives
  7. Mar 1Died In CommitteeHouse of Representatives